Pillar VC

Abridge is a pioneering company leveraging generative AI to enhance clinical conversations, aiming to improve healthcare outcomes for clinicians, nurses, and revenue cycle teams. Their platform transforms healthcare interactions into actionable insights, fostering deeper understanding and efficiency in patient-provider communication.

PathAI is transforming pathology through artificial intelligence, providing solutions for clinical development, translational research, and companion diagnostics.

Neural Magic focuses on democratizing AI through efficient and accessible tools, particularly in the realm of virtual large language models (vLLM).

Asimov provides an integrated suite of cells, genes, and software to power advanced genetic design, enabling the design and manufacture of advanced therapies.

Software Engineering Intelligence Platform that helps organizations effectively manage engineering teams, improve operational efficiency, and align engineering work with business outcomes.

Day AI offers an AI-driven CRM solution that automates data logging and provides contextual insights for businesses, enabling them to interact with their CRM through natural language queries.

Desktop Metal specializes in metal and carbon fiber 3D printing, providing high-speed production solutions for various industries. They focus on Additive Manufacturing 2.0 technologies that enable mass production, offering a range of 3D printers and engineered materials designed for optimal performance in additive manufacturing.

Algorand is a blockchain platform designed to enable decentralized applications and financial transactions. It aims to solve the blockchain trilemma of scalability, security, and decentralization.

Circle Games is a mobile gaming company that offers engaging puzzle experiences through its flagship game, Sort Express. Players are challenged to organize, match, and clear real-world 3D objects across increasingly complex levels, providing a uniquely satisfying gameplay experience.

AllHands AI is a company offering remote access and desktop app solutions for email and password management. They provide tools for remote tower access.

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease. The company’s cutting-edge approach in iPSC-thymic cell manufacturing can generate off-the-shelf cells at scale. The company is developing a pipeline of therapies to treat immunodeficiencies, transplant-related, and autoimmune disorders.

Invests in disruptive, technology-focused startups; established in 1999.

Targets companies addressing labor shortages in manufacturing, construction, logistics, and food production; cutting healthcare costs from aging and chronic disease; and enabling sustainable food production for growing populations.

Early-stage, first-money-in partner for technically ambitious founders transforming the physical world (energy, defense, infrastructure, space, advanced manufacturing), underwriting high technical and regulatory risk.

Refactor Capital is a solo GP venture fund where founders get direct access to Zal Bilimoria as the only decision-maker, applying software operator experience from Google, Netflix, and LinkedIn to hard tech sectors like aerospace, synthetic biology, and energy storage. The fund leads seed rounds with $1-2M checks targeting ~10% ownership across unusually broad hard-tech domains, backed by early hits like Solugen and Astranis.

Operates like an applied research lab with in-house engineers who build and test tech before investing in capital-intensive platforms in compute, automation, energy, and engineered biology. ~20% portfolio unicorns.